Radically resected pituitary adenomas: Prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review

Pituitary

Volumn 17, Issue 3, 2014, Pages 267-276

  Chiloiro, Sabrina ^a   Bianchi, Antonio ^a   Doglietto, Francesco ^a   De Waure, Chiara ^a   Giampietro, Antonella ^a   Fusco, Alessandra ^a   Iacovazzo, Donato ^a   Tartaglione, Linda ^a   Di Nardo, Francesco ^a   Signorelli, Francesco ^a   Lauriola, Libero ^a   Anile, Carmelo ^a   Rindi, Guido ^a   Maira, Giulio ^a   Pontecorvi, Alfredo ^a   De Marinis, Laura ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Complete removal; Disease free survival; Ki 67; Pituitary adenoma; Recurrence

Indexed keywords

CORTICOTROPIN; ESTRADIOL; FOLLITROPIN; HYDROCORTISONE; KI 67 ANTIGEN; LIOTHYRONINE; PROLACTIN; PROTEIN P53; SOMATOMEDIN C; TESTOSTERONE; THYROTROPIN; THYROXINE; XANTHOPHYLL;

ADULT; AGE; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; ENDOCRINE FUNCTION; FEMALE; FOLLOW UP; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS GRAFT; HYPOTHALAMUS HYPOPHYSIS SYSTEM; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEURORADIOLOGY; OPHTHALMOLOGY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE; UNIVARIATE ANALYSIS; ADENOMA; AGED; ENDOCRINE FUNCTION TEST; MIDDLE AGED; PITUITARY NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PITUITARY FUNCTION TESTS; PITUITARY NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84905693784     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-013-0500-6     Document Type: Article

References (40)

1. Losa M, Mortini P, Barzaghi R, Ribotto P, Terreni MR, Marzoli SB, Pieralli S, Giovanelli M (2008) Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. J Neurosurg 108(3):525-532 (Pubitemid 351357985)
2. Mastronardi L, Guiducci A, Puzzilli F (2001) Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas. BMC Cancer 1:12
3. Salehi F, Agur A, Scheithauer BW, Lloyd RV, Cusimano M (2009) Ki-67 in pituitary neoplasms: a review. Part 1. Neurosurgery 65:429-437
4. Burger PC, Shibata T, Kleihues P (1986) The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol 10:611-617 (Pubitemid 16011866)
5. Turner HE, Nagy Z, Gatter KC, Esiri MM, Wass JA, Harris AL (2000) Proliferation, bcl-2, expression and angiogenesis in pituitary adenomas: relationship to tumour behavior. Br J Cancer 82(8):1441-1445 (Pubitemid 30175911)
6. Losa M, Franzin A, Mangili F, Terreni MR, Barzaghi R, Veglia F et al (2000) Proliferation index of nonfunctioning pituitary adenomas: correlation with clinical characteristics and longterm follow up results. Neurosurgery 47:1313-1318
7. Fukui S, Otani N, Nawashiro H, Yano A, Nomura N, Miyazawa T, Ohnuki A, Tsuzuki N, Katoh H, Ishihara S, Shima K (2002) Subcellular localization of basic fibroblast growth factor and fibroblast growth factor receptor 1 in pituitary adenomas. Brain Tumor Pathol 19:23-29
8. Hsu DW, Hakim F, Biller BM et al (1993) Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 78:753-761 (Pubitemid 23121917)
9. Ramirez C, Cheng S, Vargas G, Asa S, Ezzat S, Gonzales B, Cabrera L, Guinto G, Mercado M (2012) Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3 and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistichemical study. J Clin Endocrinol Metabolism 97:1745-1751
10. Gejman R, Swearingen B, Hedly-Whyte T (2008) Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas. Hum Pathol 39:758-766 (Pubitemid 351601606)
11. Matuyama J (2012) Ki-67 expression for predicting progression of postoperative residual pituitary adenomas: correlation with clinical variables. Neurol Med Chir 52:563-569
12. Noh TW, Jeong HJ, Lee TS, Kim SH, Lee EJ (2009) Predicting recurrence of nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 94:4406-4413
13. Filippella M, Galland F, Kujas M, Young J, Faggiano A, Lombardi G, Colao A, Meduri G, Chanson P (2006) Pituitary tumor transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study. Clin Endocrinol 65(4):536-543 (Pubitemid 44414280)
14. Peak K, Kim SH, Song SH, Choi SW, Koh HS, Youm JY, Kim Y (2005) Clinical significance of Ki 67 labeling index in pituitary macroadenoma. J Korean Med Sci 20:489-494
15. Righi A, Agati P, Sisto A, Frank G, Faustini-Fustini M, Agati R, Mazzatenta D, Farnedi A, Menetti F, Marucci G, Foschini MP (2012) A classification tree approach for pituitary adenomas. Hum Pathol 43:1627-1637
16. Abe T, Sanno N, Osamura YR, Matsumoto K (1997) Proliferativepotential in pituitary adenomas: measurement by monoclonal antibody MIB-1. Acta Neurochirur. 139:613-618 (Pubitemid 27298211)
17. Mastronardi L, Guiducci A, Spera C, Puzzili F, Liberati F, Maira G (1999) Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody. J Clin Pathol 52:107-111 (Pubitemid 29062344)
18. Schreiber S, Saeger W, Ludecke DK (1999) Proliferation markers in different typer of clinically non-secreting pituitary adenomas. Pituitary 1:213-220
19. Pizarro CB, Oliveira MC, Coutinho LB, Ferreira NP (2004) Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody. Braz J Med Biol Res 37:235-243 (Pubitemid 38268156)
20. Rishi A, Sharma MC, Sarkar C, Jain D, Singh M, Mahapatra AK, Mehta VS, Das TK (2010) A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience. Neurol India 58:418-423
21. Wierinckx A, Auger C, Devauchelle P, Reynaud A, Chevallier P, Jan M, Perrin G, Fevre-Montage M, Rey C, Figarella-Branger D, Raverot G, Belin MF, Lachuer J, Trouillas J (2007) A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors endocrine-related. Cancer 14:887-900 (Pubitemid 350074076)
22. Jaffrain-Rea ML, Di Stefano D, Minniti G, Esposito V, Bultrini A, Ferretti E, Santoro A, Faticanti Scucchi L, Gulino A, Cantore G (2002) A critical reappraisal of MIB-1 labeling index significance in a large series of pituitary tumors: secreting versus nonsecreting adenomas. Endocrine Related Cancer 9:103-113 (Pubitemid 34832163)
23. Hentschel SJ, McCutcheon E, Moore W, Durity FA (2003) P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas. Can J Neurol Sci 30:215-219 (Pubitemid 37064515)
24. Dubois S, Guyetant S, Menei P, Rodien P, Fillouz F, Vielle B, Rohmer V (2007) Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery. Eur J Endocrinol 157:141-147 (Pubitemid 47233117)
25. Chacko G, Chacko AG, Kovacs K, Scheithauer BW, Mani S, Muliyil JP, Seshadri MS (2010) The clinical significance of MIB-1 index in pituitary adenomas. Pituitary 13:337-344
26. Ma W, Ikeda H, Yoshimoto T (2002) Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas. Cancer 95:258-265
27. Mete O, Ezzat S, Asa S (2012) Biomarkers of aggressive pituitary adenomas. J Mol Endocrinol 49:R69-R78
28. Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610-618 (Pubitemid 23292752)
29. Ferrante E, Ferraroni M, Castrignano T, Menicatti L, Anagni M, Reimondo G, Del Monte P, Bernasconi D, Loli P, Faustini-Fustini M, Borretta G, Terzolo M, Losa M, Morabito A, Spada A, Beck-Peccoz P, Lania AG (2006) Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol 155:823-829 (Pubitemid 46040620)
30. Brochier S, Galland F, Kujas M, Parker F, Gaillard S, Raftopoulos C, Young J, Alexopoulou O, Maiter D, Chanson P (2010) Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients. Eur J Endocrinol 163:193-200
31. Roelfsema F, Biermasz NR, Pereira AM (2012) Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 15:71-83
32. Hosmer DW, Lemeshow S (1989) Applied logistic regression. Wiley, New York
33. Fusco A, Zatelli MC, Bianchi A, Cimino V, Tilaro L, Angelini F, Lauriola L, Vellone V, Doglietto F, Ambrosio MR, Maira G, Giustina A, degli Uberti EC, Pontecorvi A, De Marinis L (2008) Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas. J Clin Endocrinol Metab 93:2746-2750 (Pubitemid 352008545)
34. Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J (1997) Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 82:2102-2107 (Pubitemid 27287568)
35. Honegger J, Prettin C, Feuerhake F, Petrick M, Schulte-Monting J, Reincke M (2003) Expression of Ki-67 antigen in nonfunctioning pituitary adenomas: correlation with growth velocity and invasiveness. J Neurosurg 99:674-679 (Pubitemid 37159044)
36. Ekramullah SM, Saitoh Y, Arita N, Ohnishi T, Hayakawa T (1996) The correlation of Ki-67 staining indices with tumor doubling times in regrowing non-functioning pituitary adenomas. Acta Neurochir 138:1449-1455 (Pubitemid 27010696)
37. Tanaka Y, Hongo K, Tada T, Sakai K, Kakizawa Y, Kobayashi S (2003) Growth pattern and rate in residual nonfunctioning pituitary adenomas and carcinomas: correlations among tumor volume doubling time, patient age, and MIB-1 index. J Neurosurg 98:359-365 (Pubitemid 36151032)
38. Zhao D, Tomono Y, Nose T (1999) Expression of P27kip1 and Ki- 67 in pituitary adenomas: an investigation of marker of adenoma invasiveness. Acta Neurochir 141:187-192 (Pubitemid 29099590)
39. Botelho CH, Magalhães AV, Mello PA, Schmitt FC, Casulari LA (2006) Expression of p53, Ki-67 and c-erb B2 in growth hormone- and/or prolactin - secreting pituitary adenomas. Arq Neuropsiquiatr 64:60-66
40. Nakabayashi H, Sunada I, Hara M (2001) Immunohistochemical analysis of cell cycle-related proteins, apoptosis, and proliferation in pituitary adenomas. J Histochem Cytochem 49:1193-1194 (Pubitemid 32800543)